Literature DB >> 32790147

Should elevated blood pressure be treated with antihypertensive drug therapy?

Wilbert S Aronow1.   

Abstract

Entities:  

Keywords:  SPRINT; antihypertensive drug therapy; elevated blood pressure; hypertension; lifestyle measures

Mesh：

Substances：

Year:  2020        PMID： 32790147      PMCID： PMC8030033          DOI： 10.1111/jch.13981

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  27 in total

1.  Prehypertension and risk of cardiovascular diseases: a meta-analysis of 47 cohort studies.

Authors:  Minghui Han; Quanman Li; Leilei Liu; Dongdong Zhang; Yongcheng Ren; Yang Zhao; Dechen Liu; Feiyan Liu; Xu Chen; Cheng Cheng; Chunmei Guo; Qionggui Zhou; Gang Tian; Ranran Qie; Shengbing Huang; Xiaoyan Wu; Yu Liu; Honghui Li; Xizhuo Sun; Ming Zhang; Dongsheng Hu
Journal:  J Hypertens       Date:  2019-12       Impact factor: 4.844

Review 2.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

3.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

4.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.

Authors:  P K Whelton; J He; J A Cutler; F L Brancati; L J Appel; D Follmann; M J Klag
Journal:  JAMA       Date:  1997-05-28       Impact factor: 56.272

5.  ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.

Authors:  Wilbert S Aronow; Jerome L Fleg; Carl J Pepine; Nancy T Artinian; George Bakris; Alan S Brown; Keith C Ferdinand; Mary Ann Forciea; William H Frishman; Cheryl Jaigobin; John B Kostis; Giuseppi Mancia; Suzanne Oparil; Eduardo Ortiz; Efrain Reisin; Michael W Rich; Douglas D Schocken; Michael A Weber; Deborah J Wesley
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

6.  Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.

Authors:  Judith E Neter; Bianca E Stam; Frans J Kok; Diederick E Grobbee; Johanna M Geleijnse
Journal:  Hypertension       Date:  2003-09-15       Impact factor: 10.190

7.  Incidence and risk factors for progression from prehypertension to hypertension: a 12-year Korean Cohort Study.

Authors:  Eun Sun Yu; Kwan Hong; Byung Chul Chun
Journal:  J Hypertens       Date:  2020-09       Impact factor: 4.844

8.  Pharmacological treatment of high-normal blood pressure (prehypertension) in high-risk patients for primary prevention of cardiovascular events.

Authors:  Roham Borazjani; Javad Kojuri; Alireza Abdi-Ardekani; Peyman Izadpanah; Pooyan Dehghani; Mehrab Sayadi; Armin Attar
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-20       Impact factor: 3.738

9.  Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.

Authors:  Sandra Costa Fuchs; Carlos E Poli-de-Figueiredo; José A Figueiredo Neto; Luiz César N Scala; Paul K Whelton; Francisca Mosele; Renato Bandeira de Mello; José F Vilela-Martin; Leila B Moreira; Hilton Chaves; Marco Mota Gomes; Marcos R de Sousa; Ricardo Pereira E Silva; Iran Castro; Evandro José Cesarino; Paulo Cesar Jardim; João Guilherme Alves; André Avelino Steffens; Andréa Araujo Brandão; Fernanda M Consolim-Colombo; Paulo Ricardo de Alencastro; Abrahão Afiune Neto; Antônio C Nóbrega; Roberto Silva Franco; Dario C Sobral Filho; Alexandro Bordignon; Fernando Nobre; Rosane Schlatter; Miguel Gus; Felipe C Fuchs; Otávio Berwanger; Flávio D Fuchs
Journal:  J Am Heart Assoc       Date:  2016-12-13       Impact factor: 5.501

10.  Lifestyle measures for treating hypertension.

Authors:  Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-06-30       Impact factor: 3.318
View more
  1 in total

1.  Should elevated blood pressure be treated with antihypertensive drug therapy?

Authors:  Wilbert S Aronow
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-13       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.